(Q50073445)

English

Neoisoliquiritigenin inhibits tumor progression by targeting GRP78-β-catenin signaling in breast cancer.

scientific article published on 14 September 2017

Statements

Neoisoliquiritigenin inhibits tumor progression by targeting GRP78-β-catenin signaling in breast cancer. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit